Lenz Therapeutics Inc (LENZ) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Lenz Therapeutics Inc   (NASDAQ: LENZ)
 

Lenz Therapeutics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the third quarter 2026, Lenz Therapeutics Inc 's inventory turnover ratio sequentially decreased to 0.58 in the third quarter 2026, unsurprisingly, as the Lenz Therapeutics Inc markets continue to deteriorate, and LENZ's faces growing challenges to bring down its inventories. Lenz Therapeutics Inc 's average inventory processing period in the Sep 30 2026 quarter, has increased to 629 days, from 589 days, in the Jun 30 2026 quarter.

Within Healthcare sector 349 other companies have achieved higher inventory turnover ratio. While inventory turnover ranking remained unchanged in the Third Quarter 2026 compared to previous quarter at no. .

LENZ Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Lenz Therapeutics Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

LENZ Inventory Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Inventory Growth 401.58 % - - - -
Y / Y Cost of Sales Growth - - - - -
Inventory Turnover Ratio (TTM) 0.58 0.62 0.81 0.43 -
LENZ's Total Ranking # # # # #
Average inventory processing period 627 592 451 848 -
Seq. Inventory Growth 15.51 % 17.81 % 19.14 % 209.38 % -
Seq. Cost of Sales Growth 62.14 % -73.98 % 157.42 % - -




Inventory Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 26
Healthcare Sector # 350
Overall Market #

Inventory Turnover Ratio Statistics
High Average Low
0.62 0.6 0.58
(Jun 30 2026)   (Sep 30 2026)



LENZ Company Profile >> Back to LENZ Efficiency Comparisons >> Compare LENZ Inventory Turnover Ratio to its Competitors

Financial Statements
Lenz Therapeutics Inc 's Inventories $ 5 Millions Visit LENZ's Balance sheet
Lenz Therapeutics Inc 's Cost of Revenues TTM $ 2 Millions Visit LENZ's Income Statement
What are LENZ's Sales? Visit LENZ's Sales by Segment

Other Inventory Turnover Ratios
Lenz Therapeutics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
LENZ's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for LENZ's Competitors
Inventory Turnover Ratio for LENZ's Suppliers
Inventory Turnover Ratio for LENZ's Customers

You may also want to know
LENZ's Sales Growth Rates LENZ's Pe Price to earnings ratio LENZ's Receivables Turnover Ratio LENZ's Stock Quote
LENZ's Net Income Growth Rates LENZ's Ps Price to Sales ratio LENZ's Sales per Employee LENZ's Asset Turnover Ratio
LENZ's Net Margin LENZ's Pb Price to Book ratio LENZ's Financial Strength Ratios LENZ's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2026 Inventories at quarter ending Sep 30 2026
Hyperfine Inc   1.28 $ 8.502  Millions$ 7  Millions
Pulmonx Corporation  1.28 $ 20.450  Millions$ 16  Millions
Alphatec Holdings Inc   1.27 $ 241.341  Millions$ 189  Millions
Si bone inc   1.25 $ 46.999  Millions$ 38  Millions
Bridgebio Pharma Inc   1.24 $ 53.542  Millions$ 43  Millions
Biogen Inc   1.23 $ 2,681.800  Millions$ 2,181  Millions
Lensar Inc   1.22 $ 28.813  Millions$ 24  Millions
Kiniksa Pharmaceuticals International Plc  1.21 $ 93.072  Millions$ 77  Millions
Mannkind Corporation  1.16 $ 51.332  Millions$ 44  Millions
Rhythm Pharmaceuticals Inc   1.14 $ 33.056  Millions$ 29  Millions
Penumbra Inc  1.13 $ 499.548  Millions$ 443  Millions
Teleflex Incorporated  1.12 $ 427.166  Millions$ 380  Millions
Acadia Pharmaceuticals Inc   1.12 $ 114.422  Millions$ 102  Millions
Corcept Therapeutics Inc  1.11 $ 14.097  Millions$ 13  Millions
Alkermes Plc   1.10 $ 300.119  Millions$ 273  Millions
Neurocrine Biosciences Inc   1.07 $ 81.200  Millions$ 76  Millions
Emergent Biosolutions Inc   1.07 $ 334.800  Millions$ 314  Millions
Seer Inc   1.03 $ 7.698  Millions$ 7  Millions
Vertex Pharmaceuticals Inc  1.00 $ 1,874.100  Millions$ 1,866  Millions
Beone Medicines Ltd   0.99 $ 701.426  Millions$ 708  Millions
Amarin Corp Plcuk  0.92 $ 104.502  Millions$ 113  Millions
Eli Lilly And Company  0.89 $ 14,149.700  Millions$ 15,815  Millions
Cerus Corporation  0.87 $ 54.000  Millions$ 62  Millions
Maxcyte inc   0.86 $ 6.538  Millions$ 8  Millions
Co diagnostics Inc   0.82 $ 0.689  Millions$ 1  Millions
Rxsight Inc   0.82 $ 29.342  Millions$ 36  Millions
Profound Medical Corp   0.79 $ 6.177  Millions$ 8  Millions
Protalix Biotherapeutics inc   0.79 $ 24.384  Millions$ 31  Millions
Inspire Medical Systems inc   0.74 $ 122.959  Millions$ 165  Millions
Butterfly Network Inc   0.62 $ 37.120  Millions$ 60  Millions

Date modified: 2026-11-04T16:54:20+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.